bioRxivBiochemistry
Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite
G. Cerutti, Y. Guo, T. Zhou, J. Gorman, M. Lee, M. Rapp, E. R. Reddem, J. Yu, F. Bahna, J. Bimela, Y. Huang, P. S. Katsamba, L. Lihong, M. S. Nair, R. Rawi, A. S. Olia, P. Wang, G.-Y. Chuang, D. D. Ho, Z. Sheng, P. D. Kwong, L. Shapiro
Abstract
Numerous antibodies that neutralize SARS-CoV-2 have been identified, and these generally target either the receptor-binding domain (RBD) or the N-terminal domain (NTD) of the viral spike. While RBD-directed antibodies have been extensively studied, far less is known about NTD-directed antibodies. Here we report cryo-EM and crystal structures for seven potent NTD-directed neutralizing antibodies in complex with spike or isolated NTD. These structures defined several antibody classes, with at least one observed in multiple convalescent donors. The structures revealed all seven antibodies to target a common surface, bordered by glycans N17, N74, N122, and N149. This site - formed primarily by a mobile {beta}-hairpin and several flexible loops - was highly electropositive, located at the periphery of the spike, and the largest glycan-free surface of NTD facing away from the viral membrane. Thus, in contrast to neutralizing RBD-directed antibodies that recognize multiple non-overlapping epitopes, potent NTD-directed neutralizing antibodies target a single supersite.
- assay: structural biology
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain
G. Cerutti, Y. Guo, … L. Shapiro·bioRxiv·Jun 29, 2021
- Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins
Z. Wang, F. Muecksch, … M. C. Nussenzweig·bioRxiv·Feb 1, 2022
- N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
M. McCallum, A. De Marco, … D. Veesler·bioRxiv·Jan 14, 2021
- A potent neutralizing human antibody reveals the N-terminal domain of the Spike protein of SARS-CoV-2 as a site of vulnerability
- Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike
L. Liu, P. Wang, … D. D. Ho·NaturePeer-reviewed·Jul 22, 2020
- The receptor binding domain of SARS-CoV-2 spike is the key target of neutralizing antibody in human polyclonal sera.
T. Steffen, E. T. Stone, … J. D. Brien·bioRxiv·Aug 21, 2020